HPS Pharmacies wish to advise that Juno Pharmaceuticals is experiencing a supply interruption for suxamethonium as follows:
Suxamethonium chloride dihydrate 100mg/2mL
Normal supplies of Suxamethonium Juno are expected to resume in early August 2023.
An internationally registered brand of suxamethonium chloride 100mg/2mL ampoules has been approved for supply under Section 19A of the Therapeutic Goods Act 1989.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Juno Pharmaceuticals on (03) 8888 1288, or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates